The Global Endotracheal Tubes market to witness growth in demand for endotracheal tubes predominantly attributed due to the increasing number of trauma cases across the globe. Another contributing factor is the surge in prevalence of neuromuscular as well as respiratory diseases along with the growing incidence of certain cancer types. Additionally, the technological advancements in product development also play a key role in establishing an upward growth trend in the Endotracheal Tubes market.
According to the latest report published by DelveInsight Endotracheal Tubes Market Insight, Competitive Landscape & Market Forecast 2027, the global Endotracheal Tubes market is expected to witness appreciable growth owing to a surge in the number of trauma cases, the entrance of major players, and an increasing incidence of cancers among other reasons. In addition to the factors stated above, the increase in the prevalence of respiratory as well as neuromuscular disorders is another contributing factor to the growth of the Endotracheal Tubes market. This has further resulted in an increased interest among manufacturers in developing and launching products. This report will provide an in-depth market understanding of the Endotracheal Tubes market which will further benefit the competitors or stakeholders operating in the Endotracheal Tubes market.
Interested in knowing how the Endotracheal Tubes market will be growing by 2027? Click to get a snapshot of Endotracheal Tubes Market Sample Report
Endotracheal Tubes Overview
An Endotracheal Tube is a flexible plastic tube that is placed through the mouth into the trachea (windpipe) to help a patient breathe which is employed in mechanical ventilation. Endotracheal Tube types constiture for oral or nasal, cuffed or uncuffed, preformed, reinforced tubes, and double-lumen Endobronchial Tubes.
Geographically, the Global Endotracheal Tubes Market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America is expected to dominate the overall Endotracheal Tubes Market during the forecast period. This domination is owing to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease, a high number of traumatic brain injuries, increasing prevalence of respiratory disorders, increasing volume of surgical procedures as well as high awareness among people regarding disease management and among other factors in the region.
Furthermore, the prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional Endotracheal Tubes market growth. Moreover, the presence of key Endotracheal Tubes players in the region and supportive reimbursement programs further provide immense growth opportunities for the Endotracheal Tubes market. For instance, in November 2020, Brian Medical Inc received the 510k product approval from the US Food and Drug Administration for their Tenax Laser Resistant Endotracheal Tube. Also, the Asia Pacific region has the future potential for growth of the Endotracheal Tubes market. This can be attributed to the sedentary and unhealthy lifestyle of the majority of the population in the region leading to various cardiovascular diseases.
Recent Developments in the Endotracheal Tubes Market report:
- American Association for Bronchology and Interventional Pulmonology recommended performing open surgical tracheostomy (OST) or percutaneous dilatational tracheostomy which involves Endotracheal Tubes in case of respiratory failure in COVID patients.
- In November 2020, Brian Medical Inc received the 510k product approval from the US Food and Drug Administration for their Tenax Laser Resistant Endotracheal Tube.
- In April 2020, Hydromer partnered with N8 Medical to become the exclusive coating supplier as well as a manufacturing partner for the latter’s CeraShield™ Endotracheal Tube.
- The U.S.-based biotech firm, N8, secured emergency use authorization from Health Canada for its CeraSheild Endotracheal Tubes in mechanically ventilated COVID-19 patients.
- Thus, owing to such developments in the Endotracheal Tubes market, there will be rapid growth observed in the Endotracheal Tubes market during the forecast period.
Want to gain a better understanding of why North America is dominating the global endotracheal tubes market? Click to get a snapshot of Endotracheal Tubes Market Analysis
Some of the key Endotracheal Tubes market players include names such as Medtronic, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc, ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd, Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co., Ltd, ROYAX, S.R.O, Sumi, HUM Gesellschaft für Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L, and others.
One of the key aspects driving the Endotracheal Tubes market is the growing demand for Endotracheal Tubes due to the increase in the number of cases due to road accidents. Severe road accidents may result in brain damage and may leave patients incapacitated to sustain breathing thereby making respiratory support through intubation extremely crucial. Respiratory support through Endotracheal Tubes intubation forms a crucial part of medicine in the intensive care units. Therefore, the rising incidents of road accidents among other causes of trauma injuries are expected to aid in the growth of Endotracheal Tubes market during the forecast period. Furthermore, another key contributor to the growth of the Endotracheal Tubes market is the increasing prevalence of various cancers. Cancer patients often suffer from respiratory insufficiency due as a result of these treatments thereby making acute respiratory failure a common complaint among patients with malignancies. Such patients are then treated with invasive and noninvasive ventilation where Endotracheal Tubes are employed. Therefore, the rising prevalence of cancers is expected to drive the growth of the Endotracheal Tubes market during the forecast period. Additionally, many drug-coated Endotracheal Tubes are in clinical development such as ISurTec Endotracheal Tubes which would help in the prevention of ventilator-assisted pneumonia cases in intubated patients is further expected to drive the Endotracheal Tubes market in the coming years.
Contrary to other medical specialties, the Endotracheal Tubes market maintained a steady pace in revenue generation even during the implementation of lockdown measures to curb the spread of the COVID-19 infection. The pandemic also paved way for emergency product approvals including Endotracheal Tubes. Nevertheless, the Endotracheal Tubes market remained undeterred by the pandemic as Endotracheal intubation is an emergency procedure and those were being catered to even during the lockdown, and with the resumption of economic activities across the globe, the future outlook for the Endotracheal Tubes market appears positive during the forecast period.
To gain a better understanding of the short/long-term impact of COVID-19 on the Endotracheal Tubes market. Get a snapshot @ Endotracheal Tubes Market Impact Due to COVID-19
Scope of the Endotracheal Tubes Market Report
- Coverage: Global
- Study Period: 2019-2027
- Market Segmentation By Product Type: Standard, Reinforced, Coated, and Others
- Market Segmentation By Cuff Type: Cuffed and Uncuffed/Cuffless
- Market Segmentation By Intubation Route: Nasal, Oral, and Others
- Market Segmentation By Age Group: Adults, Pediatrics
- Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers (ASC), and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Endotracheal Tubes Companies – Medtronic, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc, ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd, Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd, ROYAX, S.R.O, Sumi, HUM Gesellschaft für Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L, and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Delveinsight Analysis: As per DelveInsight estimates, the Global Endotracheal Tubes market was valued at USD 1.53 billion in 2021, growing at a CAGR of 4.12% during the forecast period from 2022 to 2027 to reach USD 1.95 billion by 2027.
Know more about which key player is set to dominate the Endotracheal Tubes market @ Key Endotracheal Tubes Companies
Table of Contents
|3||Regulatory and Patent Analysis|
|4||Endotracheal Tubes Market Key Factors Analysis|
|5||Endotracheal Tubes Market Porter’s Five Forces Analysis|
|6||COVID-19 Impact Analysis on Endotracheal Tubes Market|
|7||Endotracheal Tubes Market Layout|
|8||Endotracheal Tubes Market Global Company Share Analysis – Key 3-5 Companies|
|9||Endotracheal Tubes Company and Product Profiles|
Know more about Endotracheal Intubation @ Endotracheal Tubes Market Report Sample
DelveInsight’s ‘Pulse Oximeters – Market Insights, Competitive Landscape and Market Forecast – 2026’ report delivers an in-depth understanding of Pulse Oximeters, historical and forecasted Pulse Oximeters market trends, market drivers, market barriers and key companies involved like Medtronic, Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation. Meditech Equipment Co ., Ltd, and several others.
DelveInsight’s ‘Cough Assist Devices – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, market drivers & barriers, unmet needs and key companies involved such as Koninklijke Philips N.V, Percussionaire Corp., Emerson, Hill Rom, Dima Italia SRL, and many more.
DelveInsight’s, “Idiopathic Pulmonary Fibrosis – Pipeline Insight, 2021,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key companies involved like FibroGen, Vicore Pharma, Boehringer Ingelheim, AstraZeneca, Avalyn Pharmaceuticals, Indalo Therapeutics, Biosplice Therapeutics, Kinarus, CohBar, Reviva Biopharmaceuticals, J2H Biotech, Translate Bio, Daewoong Pharmaceutical, Roche, and many more.
DelveInsight’s, “Acute Respiratory Distress Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+ pipeline drugs in the Acute Respiratory Distress Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key companies involved like Faron Pharmaceuticals, BioMarck Pharmaceuticals, Athersys, Apeiron Biologics, Cynata Therapeutics, Orbsen Therapeutics, GEn1E Lifesciences, Exvastat, Longeveron, CohBar, ZyVersa Therapeutics, Abbreos, Aviceda Therapeutics, ImStem Biotechnology, Bayer and many more.
DelveInsight’s, “Chronic Obstructive Pulmonary Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products, and key companies involved like GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A, United Therapeutics Corporation, Verona Pharma plc, AstraZeneca, Immunotek, Novartis, Genentech, Vertex Pharmaceuticals, Glenmark Pharmaceuticals, EmeraMed, Afimmune, 3SBio, OmniSpirant, Rhizen Pharmaceuticals, Foresee Pharmaceuticals, Brickell Biotech and many more.
DelveInsight’s, “Interstitial Lung Diseases – Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key companies involved like AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, Bellerophon Pulse Technologies, OncoArendi Therapeutics, LTT Bio-Pharma, EmphyCorp, Genentech, Blade Therapeutics, Acceleron Pharma and many more.
DelveInsight’s, “Artificial Lung Devices–Pipeline Insight and Competitive Landscape, 2021,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the artificial lung devices pipeline landscape which includes key companies like Lung Biotechnology, Miromatrix, Charles Stark Draper Laboratory Inc, United Therapeutics Corporation, XVIVO Perfusion, Medtronic, Getinge, Xenios AG, ALung Technologies Inc., MC3 Cardiopulmonary, Abiomed and many more.
Interested to know more about the breakthrough happenings? Take a look at the posts below
- Alarming Growth of Chronic Respiratory Diseases (CRDs) and Their Prolonged Impact on the Quality of Life
- Asthma: Rising Prevalence And The Key Challenges In The Management
- Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs
- Understanding the Chronic Obstructive Pulmonary Disease Increasing Prevalence and Trends
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.